ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag new york city disease medicine immunology

Blue T cell with other blurred T cells in the background
Woman Seemingly Cured of HIV After Umbilical Cord Transplant
Natalia Mesa, PhD | Feb 16, 2022 | 3 min read
Umbilical cord blood may be a good alternative to bone marrow transplants for treating HIV in patients with HIV and cancer.
A bat flying in a dark cave
Turning on the Bat Signal
Hannah Thomasy, PhD | Mar 15, 2024 | 10+ min read
Scientists around the world investigate how bat immune systems cope with viral attacks and how this information could be used to keep humans safe.
An illustration of a pregnant women wearing a mask, surrounded by microbes
How COVID-19 Affects Pregnancy
Amanda Heidt | Aug 16, 2022 | 10 min read
Evidence thus far shows that pregnant people infected with SARS-CoV-2 are at higher risk for severe disease and death, as well as complications in their pregnancies.
A person lying on a bed checks the reading on a digital thermometer. A table with a bowl of oranges and various medications is in the background.
How Mild Is Omicron Really?
Dan Robitzski | Jan 14, 2022 | 9 min read
Early reports that Omicron causes less-severe disease than Delta seem to be borne out, but it’s not yet clear to what extent that’s due to the variant itself versus the populations it’s infecting.
NEW York-New Jersey Life Science Nirvana
Ted Agres | Apr 11, 2004 | 7 min read
Love it or hate it, if you want to play in the big leagues, the New York-New Jersey region is the place to be. From prestigous universities, medical centers, and research hospitals in Manhattan and Long Island, to major pharmaceutical research and manufacturing facilities in New Jersey, the region's life sciences can be characterized by such words as power-house and blockbuster.New York City alone (Manhattan, Brooklyn, Queens, Staten Island, and the Bronx) boasts 25 academic research and medical
Baby with spotted onsie about to get injection of vaccine
Antibiotics Tied to Lower Effectiveness of Childhood Vaccines
Natalia Mesa, PhD | Apr 28, 2022 | 2 min read
Use of the drugs in children under the age of two was associated with lower antibody levels after the jabs—perhaps, researchers suggest, due to microbiome alterations.
Woman in face shield and blue gown taking cotton swab of patient's mouth while patient sits inside of car
What You Should Know About New Omicron Subvariants
Natalia Mesa, PhD | May 17, 2022 | 6 min read
The presence and spread of new, more-infectious and immune-evading variants show that the coronavirus is not done mutating.
Sponsor Profile: Biotech and the City
The Scientist Staff | Nov 21, 2004 | 4 min read
ImClone Systems began its history as a New York company in 1984 when its founders, an immunologist and a pathologist both living and working in the city, set out to meld the established and respected world of New York City academia with the dynamic and fledgling biotechnology industry.
New York Foundation Strives To Call Attention To Diseases Of The Third World
Angela Martello | May 27, 1990 | 5 min read
As different as the developed world is from the developing world, so, too, are the diseases that plague their people. In industrialized countries, AIDS, cancer, and heart disease are prevalent; while in Africa, Asia, and South America, more than 700 million people suffer from one of three widespread tropical diseases: schistosomiasis, onchocerciasis, and trachoma. For the last 16 years, the Edna McConnell Clark Foundation, based in New York City, has done its part to help eradicate these deadl
The Pfizer/New York Story
The Scientist Staff | Nov 21, 2004 | 6 min read
Pfizer was founded in 1849 on Bartlett Street in Brooklyn.

Run a Search

ADVERTISEMENT